Mental Health Screening Guide: Depression, Anxiety, Substance Use, and Cognitive Assessment

What Is Mental Health Medicine?

Mental health medicine encompasses the diagnosis, treatment, and prevention of psychiatric disorders—conditions affecting mood, thought, behavior, and perception. Depression affects over 280 million people globally; anxiety disorders affect approximately 300 million. Fewer than half of those affected receive adequate treatment, often due to underdiagnosis and stigma. Standardized screening tools—including the PHQ-9, GAD-7, AUDIT, and Columbia Suicide Severity Rating Scale—help clinicians identify and quantify these conditions reliably.

Why Mental Health Screening Matters

Mental health conditions are among the most common health problems worldwide. Depression affects over 280 million people globally, anxiety disorders affect approximately 300 million, and substance use disorders affect tens of millions more. Despite this prevalence, mental health conditions remain significantly underdiagnosed and undertreated. Studies consistently show that fewer than half of people with depression receive any form of treatment, and the delay between symptom onset and first treatment averages several years.

Screening tools bridge this gap. They provide a structured, standardized way to identify individuals who may be experiencing a mental health condition, even when those individuals have not spontaneously reported their symptoms. Many people normalize their suffering, attribute it to stress or personality, or feel stigma around acknowledging mental health difficulties. A brief questionnaire administered in a primary care setting, an obstetric clinic, or even completed independently online can open the door to recognition, conversation, and ultimately treatment.

It is important to understand what screening tools are and what they are not. A screening tool identifies the possible presence of a condition -- it is not a diagnosis. A positive screening result should always be followed by a comprehensive clinical evaluation by a qualified professional. Screening tools are most valuable when they are part of a broader system of care that includes access to follow-up assessment and treatment.

How Is Depression Screened?

Depression is the leading cause of disability worldwide, affecting over 280 million people and contributing to approximately 700,000 suicides annually according to the World Health Organization. Depression is more than sadness. Major depressive disorder is a clinical condition characterized by persistent low mood or loss of interest in activities, accompanied by symptoms such as changes in sleep, appetite, energy, concentration, and self-worth, lasting at least two weeks. It affects how a person thinks, feels, and functions in daily life.

The PHQ-9 Calculator is the most widely used depression screening tool in clinical practice. It consists of nine items corresponding directly to the nine diagnostic criteria for major depressive disorder in the Diagnostic and Statistical Manual of Mental Disorders (DSM). Each item asks how often the respondent has been bothered by a specific symptom over the past two weeks, scored from 0 (not at all) to 3 (nearly every day). The total score ranges from 0 to 27.

PHQ-9 scores are interpreted as follows: 0 to 4 indicates minimal or no depression, 5 to 9 suggests mild depression, 10 to 14 indicates moderate depression, 15 to 19 suggests moderately severe depression, and 20 to 27 indicates severe depression. A score of 10 or above is the most commonly used threshold for identifying clinically significant depression, with a sensitivity and specificity of approximately 88 percent for major depressive disorder.

The PHQ-2 Calculator is an ultra-brief version that includes only the first two items of the PHQ-9: depressed mood and anhedonia (loss of interest or pleasure). A score of 3 or above on the PHQ-2 has good sensitivity for detecting depression and is often used as a first-step screening tool. If the PHQ-2 is positive, the full PHQ-9 is then administered for a more complete assessment.

The BDI-II Calculator is another well-established depression measure, consisting of 21 items scored from 0 to 3, yielding a total of 0 to 63. It is particularly common in psychological research and outpatient mental health settings. Scores of 0 to 13 suggest minimal depression, 14 to 19 mild, 20 to 28 moderate, and 29 to 63 severe.

The MDI Calculator is a self-report instrument developed by the World Health Organization that can be used both as a screening tool (using a simple sum score) and as a diagnostic instrument (by applying specific algorithmic criteria aligned with ICD-10 diagnostic guidelines). Its dual functionality makes it a versatile option in both research and clinical contexts.

How Is Anxiety Screened?

Anxiety disorders are the most prevalent mental health conditions worldwide, affecting approximately 301 million people; GAD has a lifetime prevalence of approximately 9% and is twice as common in women as in men. Generalized anxiety disorder (GAD) is characterized by excessive, persistent worry about a variety of topics that the individual finds difficult to control, accompanied by physical symptoms such as restlessness, muscle tension, fatigue, difficulty concentrating, irritability, and sleep disturbance. Anxiety disorders are the most prevalent mental health conditions globally.

The GAD-7 Calculator is the standard screening tool for anxiety in primary care and many other settings. Like the PHQ-9, each item is scored from 0 to 3 based on frequency over the past two weeks, yielding a total of 0 to 21. Scores of 0 to 4 indicate minimal anxiety, 5 to 9 mild anxiety, 10 to 14 moderate anxiety, and 15 to 21 severe anxiety. A score of 10 or above is the standard threshold for identifying clinically significant anxiety, with good sensitivity and specificity for GAD.

The GAD-7 also has moderate sensitivity for detecting panic disorder, social anxiety disorder, and post-traumatic stress disorder, making it a useful general anxiety screener beyond its original purpose. The GAD-2 Calculator, consisting of the first two items (feeling nervous/anxious and being unable to stop worrying), serves as a rapid screening step, with a score of 3 or above triggering the full GAD-7.

Depression and anxiety frequently co-occur. Studies show that approximately 60 percent of individuals with major depression also meet criteria for an anxiety disorder, and vice versa. This comorbidity is one reason why screening for both conditions simultaneously -- as is done in many primary care workflows using the PHQ-9 and GAD-7 together -- is considered best practice.

How Is Substance Use Screened?

Harmful alcohol use causes approximately 3 million deaths annually—5.3% of all global deaths—and is a leading risk factor for disability, accounting for 5.1% of the global burden of disease (WHO). Alcohol use disorders represent a significant global health burden, contributing to liver disease, cardiovascular disease, cancer, neurological damage, mental health disorders, injuries, and social harm. Like depression and anxiety, problematic alcohol use is frequently unrecognized in clinical settings.

The AUDIT Calculator was developed by the World Health Organization as a screening tool for hazardous and harmful drinking. It consists of 10 questions covering three domains: alcohol consumption (frequency, quantity, and binge drinking), dependence symptoms (impaired control, increased salience, morning drinking), and alcohol-related harm (guilt, blackouts, injuries, and concern from others). Each item is scored from 0 to 4, yielding a total of 0 to 40.

AUDIT scores are interpreted as follows: 0 to 7 indicates low-risk drinking, 8 to 15 suggests hazardous drinking (a pattern that increases the risk of harm), 16 to 19 indicates harmful drinking (a pattern already causing physical or mental damage), and 20 to 40 suggests possible alcohol dependence. A score of 8 or above is the standard threshold for a positive screen in most populations, though some guidelines recommend a lower threshold of 4 or 5 for women and older adults.

The CAGE Questionnaire is an older, briefer screening tool consisting of four yes/no questions: Have you ever felt you should Cut down on your drinking? Have people Annoyed you by criticizing your drinking? Have you ever felt Guilty about your drinking? Have you ever had a drink first thing in the morning as an Eye-opener? Two or more positive responses suggest a significant alcohol problem. While less sensitive than the AUDIT for detecting hazardous drinking patterns, the CAGE remains widely used due to its simplicity and its effectiveness at identifying more severe alcohol use disorders and dependence.

How Is Perinatal Mental Health Screened?

The perinatal period -- encompassing pregnancy and the first year after childbirth -- is a time of heightened vulnerability for mental health conditions. Perinatal depression affects approximately 10 to 20 percent of women and can have serious consequences for the mother, infant, and family. Perinatal anxiety is similarly common and often co-occurs with depression.

The EPDS Calculator is the most widely validated screening tool for perinatal depression. Despite its name, it is appropriate for use during pregnancy as well as the postpartum period. It consists of 10 items scored from 0 to 3, yielding a total of 0 to 30. A score of 13 or above is the traditional threshold for probable major depression, while a score of 10 or above is often used as a more sensitive cutoff for identifying women who would benefit from further assessment.

Notably, item 10 of the EPDS asks specifically about self-harm ("The thought of harming myself has occurred to me"). Any positive response to this item, regardless of the total score, should prompt immediate follow-up and safety assessment. The EPDS is recommended for routine use in obstetric and pediatric settings by professional organizations including the American College of Obstetricians and Gynecologists and the American Academy of Pediatrics.

How Is PTSD Assessed?

PTSD affects approximately 3.9% of the global population; among combat veterans, rates reach 10–30%, and among sexual assault survivors, approximately 30–50% develop the disorder (WHO, PTSD Alliance). Post-traumatic stress disorder (PTSD) can develop after exposure to a traumatic event such as combat, sexual assault, a serious accident, natural disaster, or witnessing violence. Symptoms cluster into four categories: intrusion (flashbacks, nightmares, intrusive memories), avoidance (avoiding reminders of the trauma), negative alterations in cognition and mood (persistent negative beliefs, emotional numbness, detachment), and hyperarousal (hypervigilance, exaggerated startle response, sleep disturbance, irritability).

The PCL-5 Calculator is a 20-item self-report measure that assesses the 20 symptoms of PTSD as defined by the DSM-5. Each item is rated from 0 (not at all) to 4 (extremely) based on the past month, yielding a total of 0 to 80. A score of 31 to 33 is the recommended threshold for probable PTSD, though this cutoff may be adjusted depending on the population and clinical context.

The PCL-5 can also be scored by symptom cluster, allowing clinicians to assess the prominence of intrusion, avoidance, cognitive/mood, and arousal symptoms independently. This pattern can inform treatment planning, as different symptom clusters may respond to different therapeutic approaches.

How Is Suicide Risk Assessed?

Suicide claims approximately 700,000 lives annually worldwide—1 person every 40 seconds—and is the fourth leading cause of death among people aged 15–29, according to the World Health Organization. Suicide is a leading cause of death across all age groups. Screening for suicide risk is a critical component of mental health assessment, yet many clinicians feel uncertain about how to ask about suicidal thoughts. Structured tools help overcome this barrier.

The C-SSRS Calculator is one of the most widely adopted suicide risk screening and assessment instruments in the world. It distinguishes between suicidal ideation (thoughts) and suicidal behavior (actions), and it further classifies ideation by severity: passive ideation (wishing one were dead), active ideation without a plan, active ideation with a plan, and ideation with intent to act. This graduated assessment allows for more precise risk stratification than a simple yes/no question about suicidal thoughts.

The C-SSRS has been adopted by the FDA, the U.S. military, numerous hospital systems, and crisis hotlines. Its strength lies in its systematic approach: by walking through a defined sequence of questions, it helps ensure that no critical dimension of suicide risk is overlooked.

If you or someone you know is experiencing suicidal thoughts, please contact emergency services or a crisis helpline such as the 988 Suicide and Crisis Lifeline (call or text 988 in the United States) immediately.

How Is Cognitive Function Assessed?

Dementia affects approximately 55 million people worldwide, with nearly 10 million new cases diagnosed each year; early cognitive screening with tools like the MoCA identifies at-risk individuals when intervention is most effective (WHO 2023). Cognitive screening is used to detect impairments in memory, attention, language, visuospatial function, and executive function. Such impairments may indicate conditions ranging from mild cognitive impairment to dementia, including Alzheimer's disease, vascular dementia, and Lewy body dementia.

The MMSE Calculator was for decades the most widely used cognitive screening tool. It assesses orientation, registration, attention and calculation, recall, language, and visuospatial ability, yielding a total score of 0 to 30. A score below 24 is the traditional threshold for cognitive impairment, though educational level and age should be considered when interpreting results. The MMSE has known limitations, including a ceiling effect (it may not detect mild impairment in highly educated individuals) and poor sensitivity for executive dysfunction and visuospatial problems.

The MoCA Calculator was developed specifically to address these limitations. It is more sensitive than the MMSE for detecting mild cognitive impairment and includes more challenging items assessing executive function (trail-making, verbal abstraction), visuospatial ability (cube copy, clock drawing), and delayed recall. Like the MMSE, it yields a score out of 30, with 26 or above considered normal. One point is added for individuals with 12 or fewer years of education.

Both tools are designed for administration by trained professionals and should be interpreted in the context of the patient's baseline cognitive function, educational background, cultural factors, and current medical status. Conditions such as delirium, depression, sleep deprivation, and medication effects can transiently impair cognitive test performance.

When to Seek Professional Help

Mental health conditions are treatable, and the earlier treatment begins, the better the outcomes tend to be. Consider seeking professional help if you experience any of the following: persistent feelings of sadness, hopelessness, or emptiness lasting more than two weeks; excessive worry or fear that interferes with daily activities; significant changes in sleep, appetite, or energy without a clear physical cause; withdrawal from social activities or relationships; difficulty fulfilling responsibilities at work, school, or home; increased use of alcohol or other substances to cope; or any thoughts of self-harm or suicide.

A positive result on any of the screening tools described in this guide is not a diagnosis, but it is a meaningful signal that professional evaluation is warranted. Treatment options for mental health conditions include psychotherapy (such as cognitive behavioral therapy), medication, lifestyle modifications, peer support, and various combinations of these approaches. The right treatment plan depends on the individual's specific condition, preferences, and circumstances.

The screening tools on this site are provided for educational purposes and to encourage awareness. They are not substitutes for professional clinical assessment. If your results concern you, please reach out to a healthcare provider, mental health professional, or crisis service.